Join to View Full Profile
161 Fort Washington AveNew York, NY 10032
Phone+1 212-305-5098
Dr. Schwartz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1986 - 1988
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1985 - 1986- Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1983 - 1984
Albany Medical CollegeClass of 1983
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 1984 - 2027
OH State Medical License 2023 - 2027
NJ State Medical License 2022 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2015-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2015-2017
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2015-2017
Clinical Trials
- Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer Start of enrollment: 1995 Apr 01
- Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors Start of enrollment: 1997 Jul 01
- Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid Tumors Start of enrollment: 1998 Feb 01
Publications & Presentations
PubMed
- Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.Alice P Chen, Christina L Rosenberger, Nancy Moore, Jared C Foster, Abdul Rafeh Naqash
Journal of Clinical Oncology. 2026-04-18 - Tissue-Specific Expression of the EWSR1::FLI1 Fusion Protein Identifies-Positive Cells as a Source of Ewing Sarcoma-like Tumors in Zebrafish.Rebecca A Anderson, Xin Chen, Usua Oyarbide, Nicolas J Alvarez, Aidan Sievers
International Journal of Molecular Sciences. 2026-03-30 - Oncostatin-M ligand-based CAR-T therapy displays robust anti-tumor activity against osteosarcoma.Daniel Feinberg, Vinayak Uppin, Saada Eid, Claire Fritz, Masahiro Hitomi
BMC Medicine. 2026-03-17
Journal Articles
- Sorafenib for Advanced and Refractory Desmoid TumorsGary Schwartz, MD, The New England Journal of Medicine
Press Mentions
Sequencing Matters – Combination Dabrafenib/Trametinib Versus Nivolumab/Ipilimumab for Advanced BRAF-Mutant Melanoma: The DREAMseq TrialMarch 9th, 2023
Angiosarcoma Research Project Produces Windfall of Druggable InsightsApril 8th, 2020
Six Columbia Cancer Researchers Receive Seed Funding from VelocityJuly 15th, 2019
Grant Support
- Clinical Oncology Research Program (CORP)CASE WESTERN RESERVE UNIVERSITY2025–2030
- Case Comprehensive Cancer Center Support GrantCASE WESTERN RESERVE UNIVERSITY1997–2030
- P2 - Developing New Strategies For Targeting Pdgfr/Pi3k/Akt Pathways In SarcomaNational Cancer Institute2010–2011
- Developing New Strategies For Targeting Mtor And Igf-1r/Pi3k/Akt Pathways In SarcNational Cancer Institute2009–2011
- Translational Research Studies In Clinical Trials Of Novel Therapeutics For SarcoNational Cancer Institute2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
